Shaun Baggarley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shaun Baggarley has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Amarjit Kaur
Nanyang Polytechnic, School of Health Sciences, 180 Ang Mo Kio Avenue 8 Singapore 569830
2 shared publications - Jiade Jay Lu
National University Cancer Institute, National University Health System, National University of Singapore
2 shared publications - Khai Mun Lee
National University Cancer Institute, Department of Radiation Oncology, National University of Singapore, 1E Kent Ridge Road, Tower Block, Level 7, Singapore 119 228
2 shared publications - Michael Back
Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, New South Wales 2065, Australia
2 shared publications - Sharon Wong
National University of Singapore, Yong Loo Lin School of Medicine, 21 Lower Kent Ridge Road, Singapore 119077
2 shared publications - A Elliott
College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
1 shared publication
Latest Publications
- 1 July 2015
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 88 (1051) , 20140645
A dual two dimensional electronic portal imaging device transit dosimetry model based on an empirical quadratic formalism
This study describes a two dimensional electronic portal imaging device (EPID) transit dosimetry model that can predict either: (1) in-phantom exit dose, or (2) EPID transit dose, for treatment verification. The model was based on a quadratic equation that relates the reduction in intensity to the equivalent path length (EPL) of the attenuator. In this study, two sets of quadratic equation coefficients were derived from calibration dose planes measured with EPID and ionization chamber in water under reference conditions. With two sets of coefficients, EPL can be calculated from either EPID or treatment planning system (TPS) dose planes. Consequently, either the in-phantom exit dose or the EPID transit dose can be predicted from the EPL. The model was tested with two open, five wedge and seven sliding window prostate and head and neck intensity-modulated radiation therapy (IMRT) fields on phantoms. Results were analysed using absolute gamma analysis (3%/3 mm). The open fields gamma pass rates were >96.8% for all comparisons. For wedge and IMRT fields, comparisons between predicted and TPS-computed in-phantom exit dose resulted in mean gamma pass rate of 97.4% (range, 92.3-100%). As for the comparisons between predicted and measured EPID transit dose, the mean gamma pass rate was 97.5% (range, 92.6-100%). An EPID transit dosimetry model that can predict in-phantom exit dose and EPID transit dose was described and proven to be valid. The described model is practical, generic and flexible to encourage widespread implementation of EPID dosimetry for the improvement of patients' safety in radiotherapy.
- 1 July 2015
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 88 (1051) , 20140645
A dual two dimensional electronic portal imaging device transit dosimetry model based on an empirical quadratic formalism
This study describes a two dimensional electronic portal imaging device (EPID) transit dosimetry model that can predict either: (1) in-phantom exit dose, or (2) EPID transit dose, for treatment verification. The model was based on a quadratic equation that relates the reduction in intensity to the equivalent path length (EPL) of the attenuator. In this study, two sets of quadratic equation coefficients were derived from calibration dose planes measured with EPID and ionization chamber in water under reference conditions. With two sets of coefficients, EPL can be calculated from either EPID or treatment planning system (TPS) dose planes. Consequently, either the in-phantom exit dose or the EPID transit dose can be predicted from the EPL. The model was tested with two open, five wedge and seven sliding window prostate and head and neck intensity-modulated radiation therapy (IMRT) fields on phantoms. Results were analysed using absolute gamma analysis (3%/3 mm). The open fields gamma pass rates were >96.8% for all comparisons. For wedge and IMRT fields, comparisons between predicted and TPS-computed in-phantom exit dose resulted in mean gamma pass rate of 97.4% (range, 92.3-100%). As for the comparisons between predicted and measured EPID transit dose, the mean gamma pass rate was 97.5% (range, 92.6-100%). An EPID transit dosimetry model that can predict in-phantom exit dose and EPID transit dose was described and proven to be valid. The described model is practical, generic and flexible to encourage widespread implementation of EPID dosimetry for the improvement of patients' safety in radiotherapy.
- Open Access
- 18 February 2011
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 18
Erratum To: An ultrasonographic evaluation of skin thickness in breast cancer patients after postmastectomy radiation therapy
- 18 February 2011
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 18
Open AccessErratum To: An ultrasonographic evaluation of skin thickness in breast cancer patients after postmastectomy radiation therapy
- Open Access
- 24 January 2011
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 9
An ultrasonographic evaluation of skin thickness in breast cancer patients after postmastectomy radiation therapy
Background: To determine the usefulness of ultrasonography in the assessment of post radiotherapy skin changes in postmastectomy breast cancer patients. Methods: Patients treated for postmastectomy radiotherapy in National University Hospital (NUH) and Tan Tock Seng Hospital (TTSH), Singapore between January 2004- December 2005 was recruited retrospectively. Ultrasound scan was performed on these Asian patients who had been treated to a total dose of 46-50 Gy with 1 cm bolus placed on the skin. The ultrasound scans were performed blinded to the RTOG scores, and the skin thickness of the individually marked points on the irradiated chest wall was compared to the corresponding points on the non-irradiated breast. Results: The mean total skin thickness inclusive of the epidermis and the dermis of the right irradiated chest wall was 0.1712 mm (± 0.03392 mm) compared with the contra-lateral non-irradiated breast which was 0.1845 mm (± 0.04089 mm; p = 0.007). The left irradiated chest wall had a mean skin thickness of 0.1764 mm (± 0.03184 mm) compared with the right non-irradiated breast which was 0.1835 mm (± 0.02584 mm; p = 0.025). These independent t-tests produced a significant difference of reduced skin thickness on the right irradiated chest wall, p = 0.007 (p < 0.05) and left irradiated chest wall p = 0.025 (p < 0.025) in comparison to the non-irradiated skin thickness investigating chronic skin reactions. Patients with grade 2 acute skin toxicity presented with thinner skin as compared to patients with grade 1 (p = 0.006). Conclusions: This study has shown that there is a statistically significant difference between the skin thicknesses of the irradiated chest wall and the contra-lateral non-irradiated breast and a predisposition to chronic reactions was found in patients with acute RTOG scoring of grade1 and grade 2.
- 24 January 2011
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 9
Open AccessAn ultrasonographic evaluation of skin thickness in breast cancer patients after postmastectomy radiation therapy
Background: To determine the usefulness of ultrasonography in the assessment of post radiotherapy skin changes in postmastectomy breast cancer patients. Methods: Patients treated for postmastectomy radiotherapy in National University Hospital (NUH) and Tan Tock Seng Hospital (TTSH), Singapore between January 2004- December 2005 was recruited retrospectively. Ultrasound scan was performed on these Asian patients who had been treated to a total dose of 46-50 Gy with 1 cm bolus placed on the skin. The ultrasound scans were performed blinded to the RTOG scores, and the skin thickness of the individually marked points on the irradiated chest wall was compared to the corresponding points on the non-irradiated breast. Results: The mean total skin thickness inclusive of the epidermis and the dermis of the right irradiated chest wall was 0.1712 mm (± 0.03392 mm) compared with the contra-lateral non-irradiated breast which was 0.1845 mm (± 0.04089 mm; p = 0.007). The left irradiated chest wall had a mean skin thickness of 0.1764 mm (± 0.03184 mm) compared with the right non-irradiated breast which was 0.1835 mm (± 0.02584 mm; p = 0.025). These independent t-tests produced a significant difference of reduced skin thickness on the right irradiated chest wall, p = 0.007 (p < 0.05) and left irradiated chest wall p = 0.025 (p < 0.025) in comparison to the non-irradiated skin thickness investigating chronic skin reactions. Patients with grade 2 acute skin toxicity presented with thinner skin as compared to patients with grade 1 (p = 0.006). Conclusions: This study has shown that there is a statistically significant difference between the skin thicknesses of the irradiated chest wall and the contra-lateral non-irradiated breast and a predisposition to chronic reactions was found in patients with acute RTOG scoring of grade1 and grade 2.